Wordt geladen...
Pharmacokinetics of quinacrine in the treatment of prion disease
BACKGROUND: Prion diseases are caused by the accumulation of an aberrantly folded isoform of the prion protein, designated PrP(Sc). In a cell-based assay, quinacrine inhibits the conversion of normal host prion protein (PrP(C)) to PrP(Sc )at a half-maximal concentration of 300 nM. While these data s...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2004
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC535929/ https://ncbi.nlm.nih.gov/pubmed/15569390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-4-53 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|